Image
Loading
Image
3 Νοεμβρίου, 2024

PR status cannot predict Oncotype DX Recurrence Score®: a study in a Greek cohort of N0M0/ER+/PR-/HER2- breast cancer patients tested with Oncotype DX

Venizelos V., Iosifidou R., Markopoulos C., Xepapadakis G., Tsoulos N., Giannoulakis S., Kapetsis G., Psyrri A., Saridaki Z., Natsiopoulos I., Nikolaidi A., Savvidou A., Mpoutis A., Mpoukovinas I., Kotsakis A., Christopoulou A., Saloustros E., Mavroudis D., Aggelaki S., Assi A., Tzanninis D., Grosomanidis D., Fountzilas E., Lala E., Ignatiadou E., Skondra M., Zagouri F., Koumarianou A., Kosmidis P., Douvetzemis S., Papazisis K., Anastasakou K., Pavlidou F., Kampletsas E., Poulakaki F., Simpilidis G., Triantafillidou S., Stathoulopoulou M.